Security National Trust’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-12,153
| Closed | -$1.6M | – | 393 |
|
|
2021
Q2 | $1.6M | Sell |
12,153
-255
| -2% | -$33.4K | 0.36% | 77 |
|
|
2021
Q1 | $1.59M | Buy |
12,408
+180
| +1% | +$22.2K | 0.37% | 75 |
|
|
2020
Q4 | $1.46M | Buy |
12,228
+410
| +3% | +$50K | 0.36% | 73 |
|
|
2020
Q3 | $1.35M | Hold |
11,818
| – | – | 0.38% | 72 |
|
|
2020
Q2 | $1.35M | Buy |
11,818
+1,016
| +9% | +$108K | 0.4% | 71 |
|
|
2020
Q1 | $868K | Sell |
10,802
-16
| -0.1% | -$1.66K | 0.32% | 78 |
|
|
2019
Q4 | $1.16M | Sell |
10,818
-95
| -0.9% | -$9.91K | 0.34% | 78 |
|
|
2019
Q3 | $1.17M | Hold |
10,913
| – | – | 0.37% | 77 |
|
|
2019
Q2 | $1.11M | Sell |
10,913
-100
| -0.9% | -$9.61K | 0.35% | 76 |
|
|
2019
Q1 | $990K | Sell |
11,013
-120
| -1% | -$10.4K | 0.32% | 78 |
|
|
2018
Q4 | $927K | Sell |
11,133
-250
| -2% | -$23.4K | 0.34% | 77 |
|
|
2018
Q3 | $1.23M | Sell |
11,383
-25
| -0.2% | -$2.74K | 0.39% | 73 |
|
|
2018
Q2 | $1.25M | Hold |
11,408
| – | – | 0.42% | 69 |
|
|
2018
Q1 | $1.15M | Sell |
11,408
-31
| -0.3% | -$3.17K | 0.38% | 71 |
|
|
2017
Q4 | $1.13M | Sell |
11,439
-222
| -2% | -$21K | 0.36% | 75 |
|
|
2017
Q3 | $1.09M | Sell |
11,661
-334
| -3% | -$35.5K | 0.36% | 77 |
|
|
2017
Q2 | $1.33M | Sell |
11,995
-50
| -0.4% | -$5.29K | 0.45% | 68 |
|
|
2017
Q1 | $1.18M | Sell |
12,045
-125
| -1% | -$11.9K | 0.4% | 71 |
|
|
2016
Q4 | $1.12M | Sell |
12,170
-75
| -0.6% | -$6.46K | 0.4% | 68 |
|
|
2016
Q3 | $1.04M | Sell |
12,245
-100
| -0.8% | -$8.4K | 0.38% | 70 |
|
|
2016
Q2 | $1M | Sell |
12,345
-116
| -0.9% | -$8.83K | 0.37% | 72 |
|
|
2016
Q1 | $890K | Sell |
12,461
-914
| -7% | -$61.3K | 0.33% | 77 |
|
|
2015
Q4 | $951K | Sell |
13,375
-100
| -0.7% | -$6.72K | 0.37% | 72 |
|
|
2015
Q3 | $828K | Sell |
13,475
-116
| -0.9% | -$8.11K | 0.32% | 76 |
|
|
2015
Q2 | $986K | Sell |
13,591
-100
| -0.7% | -$7.38K | 0.35% | 73 |
|
|
2015
Q1 | $1.05M | Sell |
13,691
-400
| -3% | -$28.6K | 0.37% | 70 |
|
|
2014
Q4 | $945K | Sell |
14,091
-655
| -4% | -$41.3K | 0.34% | 72 |
|
|
2014
Q3 | $895K | Sell |
14,746
-37
| -0.3% | -$2.28K | 0.36% | 69 |
|
|
2014
Q2 | $868K | Sell |
14,783
-1,525
| -9% | -$89.3K | 0.34% | 73 |
|
|
2014
Q1 | $945K | Sell |
16,308
-1,150
| -7% | -$61.6K | 0.38% | 71 |
|
|
2013
Q4 | $934K | Sell |
17,458
-450
| -3% | -$26.7K | 0.39% | 68 |
|
|
2013
Q3 | $1.11M | Buy |
17,908
+1,058
| +6% | +$63.3K | 0.5% | 56 |
|
|
2013
Q2 | $1.02M | Buy |
+16,850
| New | +$1M | 0.49% | 55 |
|
Other funds holding DGX
FMI
DSA
Security National Trust's DGX Position: Q3 2021 in Review
Security National Trust sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 12,153 shares — an estimated $1.6M sold.
Security National Trust first reported a position in DGX in Q2 2013 and held it in 33 quarters. The position peaked at $1.6M in Q2 2021. 837 funds tracked by Wall St. Rank hold DGX as of Q3 2021.
- Security National Trust reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
- Security National Trust sold 12,153 Quest Diagnostics shares in Q3 2021, an estimated $1.6M.
- Security National Trust first reported a position in Quest Diagnostics in Q2 2013 and held it in 33 quarters.
- Security National Trust's Quest Diagnostics position peaked at $1.6M in Q2 2021.
- 837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.
Based on Security National Trust's 13F filing for Q3 2021, filed 4 Oct 2021.